共 166 条
[1]
Lunn MP(1999)Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England J Neurol Neurosurg Psychiatry 66 677-680
[2]
Manji H(2015)Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype J Neurol Neurosurg Psychiatry 86 973-985
[3]
Choudhary PP(2010)European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision Eur J Neurol 17 356-363
[4]
Hughes RA(2013)Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy Cochrane Database Syst Rev 12 245-253
[5]
Thomas PK(2010)Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial Lancet Neurol. 9 802-807
[6]
Mathey EK(2010)Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy Arch Neurol 67 1079-1084
[7]
Park SB(2012)Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment Neurology. 78 493-502
[8]
Hughes RA(2012)Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial Lancet Neurol 11 506-13
[9]
Pollard JD(2019)Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study Eur J Neurol. 27 337-345
[10]
Armati PJ(2011)Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies Neurology. 76 136-144